2-(Perfluorobutyl)ethyl acrylate – (52591-27-2)

43067-01-2, dimethyl 4-(2-chlorophenyl)-2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate, Amlodipine besilate impurity G, UNII-LWR56J17GQ, LWR56J17GQ, Calcium Channel antagonist 1, DTXSID10195673, 3, 5-dimethyl 4-(2-chlorophenyl)-2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate, AMLODIPINE BESILATE IMPURITY G [EP IMPURITY], Amlodipine EP Impurity G, (+/-)-4-(2-CHLOROPHENYL)-3, 5-DI(METHOXYCARBONYL)-2, 6-DIMETHYL-1, 4-DIHYDROPYRIDINE, 4-(2-CHLOROPHENYL)-3, 5-DI(METHOXYCARBONYL)-2, 6-DIMETHYL-1, 4-DIHYDROPYRIDINE, 3, 5-PYRIDINEDICARBOXYLIC ACID, 4-(2-CHLOROPHENYL)-1, 4-DIHYDRO-2, 6-DIMETHYL-, 3, 5-DIMETHYL ESTER, 3, 5-PYRIDINEDICARBOXYLIC ACID, 4-(2-CHLOROPHENYL)-1, 4-DIHYDRO-2, 6-DIMETHYL-, DIMETHYL ESTER, AMLODIPINE BESILATE IMPURITY G (EP IMPURITY), starbld0009021, Oprea1_397112, Oprea1_609948, CHEMBL63997, SCHEMBL3035724, CHEMBL2063643, DTXCID50118164, REIGLQUFMMOAFU-UHFFFAOYSA-N, HMS3428M07, TBA06701, STK387362, AKOS000572278, HY-W278072, dimethyl 4-(2-chlorophenyl)-1, 4-dihydro-2, 6-dimethylpyridine-3, 5-dicarboxylate, AS-87127, DB-326234, CS-0323200, EU-0035198, F19309, SR-01000403200, SR-01000403200-1, Q27283227, Amlodipine impurity G, European Pharmacopoeia (EP) Reference Standard